Nineth Amendment to the License Agreement, dated October 21, 2021, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research
Exhibit 10.40
LICENSE AGREEMENT
AMENDMENT #9
WHEREAS, effective as of December 1, 2014, and as further amended, Miromatrix Medical Inc., a corporation organized under the laws of the State of Delaware and having an office 10399 West 70th Street, Eden Prairie, MN 55344 (“Miromatrix”) and Mayo Foundation for Medical Education and Research, a not for profit corporation with an address at 200 First Street SW, Rochester, MN 55905 (“Mayo”) executed a License Agreement (the “Agreement”) for Services as outlined in the Agreement.
WHEREAS, Miromatrix and Mayo wish to amend said Agreement.
NOW, THEREFORE, Miromatrix and Mayo agree as follows:
| 1. | The Term of the Agreement shall be extended to March 31, 2022. |
| 2. | Miromatrix has agreed to provide additional funding of $279,500 due to the unplanned increase in the consumption of cell culture media components. Accordingly, the attached Exhibit B-5 shall amend Section 3 of the Agreement. |
| 3. | Except as specifically provided herein, the terms and conditions of the Agreement shall remain in force. |
IN WITNESS WHEREOF, the Parties have executed this Amendment which shall be effective as of the last dated signature below.
MIROMATRIX MEDICAL INC.MAYO FOUNDATION FOR MEDICAL
EDUCATION AND RESEARCH
By: /s/ Jeff Ross By: /s/ Tara Rabe
Name: Jeff Ross Name: Tara Rabe
Title: CEO Title: Administrator
Date: 10/21/2021 Date: 10/4/2021
Budget – Exhibit B-5
